Skip to content
Application 075431
- Type
- ANDA
- Sponsor
- AKORN INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | INJECTABLE;INJECTION | 5MG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 17478-420 | Labetalol Hydrochloride | Labetalol Hydrochloride | Akorn, Inc. | ANDA | Current |
| 17478-420 | Labetalol Hydrochloride | Labetalol Hydrochloride | Akorn, Inc. | ANDA | Current |
| 17478-420 | Labetalol Hydrochloride | Labetalol Hydrochloride | Akorn | ANDA | Current |
| 17478-420 | Labetalol Hydrochloride | Labetalol Hydrochloride | Akorn, Inc. | ANDA | Current |
| 17478-420 | Labetalol Hydrochloride | Labetalol Hydrochloride | Akorn | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 30883 | ORIG | 1999-12-29 |